Literature DB >> 2137111

Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets.

M Kobisch1, P Novotny.   

Abstract

Maternal antibody to an outer membrane 68-kilodalton (kDa) protein of Bordetella bronchiseptica was shown to be protective in experiments on specific-pathogen-free piglets. After challenge with B. bronchiseptica, 100% (n = 19) control piglets from nonimmunized sows developed pneumonia, coughing, and sneezing, and 74% of the animals developed severe atrophic rhinitis. In 12 piglets from a sow immunized with 68-kDa protein, pneumonia occurred only in 34% of offspring, coughing was reduced, the duration of coughing bouts was shortened, and severe atrophic rhinitis occurred in one animal only (8%). The difference in the occurrence of atrophic rhinitis and of pneumonia in immunized and nonimmunized offspring was statistically significant (P less than 0.05). Sera of protected piglets had high titers (enzyme-linked immunosorbent assay) of antibodies that showed a high specificity for the 68-kDa protein isolated from B. bronchiseptica, whereas their reactivity with an analogous 69-kDa protein isolated from Bordetella pertussis was low or absent. The 68-kDa protein of B. bronchiseptica appeared to be the major protective antigen in B. bronchiseptica infection; however, isolated protein alone did not induce such a solid protection, as observed in a previous study after the application of an effective whole cell vaccine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137111      PMCID: PMC258462          DOI: 10.1128/iai.58.2.352-357.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay.

Authors:  P Novotny; M Kobisch; K Cownley; A P Chubb; J A Montaraz
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

2.  Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica.

Authors:  J A Montaraz; P Novotny; J Ivanyi
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

3.  Influence of potential virulence determinants on Bordetella bronchiseptica-induced ciliostasis.

Authors:  D A Bemis; S A Wilson
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

4.  Potentiation of turbinate atrophy in pigs by long-term nasal colonization with Pasteurella multocida.

Authors:  M Gois; H J Barnes; R F Ross
Journal:  Am J Vet Res       Date:  1983-03       Impact factor: 1.156

5.  Purification and characterization of a calmodulin-sensitive adenylate cyclase from Bordetella pertussis.

Authors:  R L Shattuck; D J Oldenburg; D R Storm
Journal:  Biochemistry       Date:  1985-11-05       Impact factor: 3.162

6.  Adenylate cyclase activity of a 68,000-molecular-weight protein isolated from the outer membrane of Bordetella bronchiseptica.

Authors:  P Novotny; A P Chubb; K Cownley; J A Montaraz
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Biochemical and immunological analyses of the cell surface of Bordetella bronchiseptica isolates with special reference to atrophic rhinitis in swine.

Authors:  B Lugtenberg; R van Boxtel; R van den Bosch; M de Jong; P Storm
Journal:  Vaccine       Date:  1984-12       Impact factor: 3.641

8.  Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.

Authors:  J M Rutter
Journal:  Res Vet Sci       Date:  1983-05       Impact factor: 2.534

9.  Pertussis.

Authors:  L C Olson
Journal:  Medicine (Baltimore)       Date:  1975-11       Impact factor: 1.889

10.  Bordetella extracytoplasmic adenylate cyclase: actions as a bacterial toxin.

Authors:  E L Hewlett; A A Weiss; J K Crane; R D Pearson; H J Anderson; G A Myers; W S Evans; L L Hantske; H D Kay; M J Cronin
Journal:  Dev Biol Stand       Date:  1985
View more
  10 in total

1.  Novel genetic and phenotypic heterogeneity in Bordetella bronchiseptica pertactin.

Authors:  K B Register
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Derivation of a physical map of the chromosome of Bordetella pertussis Tohama I.

Authors:  S Stibitz; T L Garletts
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

3.  Antibody responses to Bordetella bronchiseptica in vaccinated and infected dogs.

Authors:  John Ellis; Carrie Rhodes; Stacey Lacoste; Steven Krakowka
Journal:  Can Vet J       Date:  2014-09       Impact factor: 1.008

4.  Pertactin is required for Bordetella species to resist neutrophil-mediated clearance.

Authors:  Carol S Inatsuka; Qian Xu; Ivan Vujkovic-Cvijin; Sandy Wong; Scott Stibitz; Jeff F Miller; Peggy A Cotter
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

5.  Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica.

Authors:  C Boursaux-Eude; N Guiso
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica.

Authors:  B J Akerley; D M Monack; S Falkow; J F Miller
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

9.  Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.

Authors:  Zhanqin Zhao; Yun Xue; Bin Wu; Xibiao Tang; Ruiming Hu; Yindi Xu; Aizhen Guo; Huanchun Chen
Journal:  Infect Immun       Date:  2008-02-11       Impact factor: 3.441

10.  Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system.

Authors:  B J Akerley; J F Miller
Journal:  J Bacteriol       Date:  1993-06       Impact factor: 3.490

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.